East Sussex - Better Together
NHS

7.3.1 Combined hormonal contraceptives

CHCs containing no more than 35 micrograms ethinylestradiol plus no more than 1 mg norethisterone or 150 micrograms levonorgestrel are recommended as first-line agents

Standard strength tablets containing ethinylestradiol 30 micrograms and levonorgestrel 150 micrograms

Pack
63 tablet (3 x 21 tablets)

Low strength tablets containing ethinylestradiol 20 micrograms and gestodene 75 micrograms

Pack
63 tablet (3 x 21 tablets)

Standard strength tablets containing ethinylestradiol 30 micrograms and gestodene 75 micrograms

Pack
63 tablet (3 x 21 tablets)

Low strength tablets containing ethinylestradiol 20 micrograms and norethisterone 1 mg

Pack
63 tablet (3 x 21 tablets)

Standard strength tablets containing ethinylestradiol 30 micrograms and norethisterone 1.5 mg

Pack
63 tablet (3 x 21 tablets)

Standard strength tablets containing ethinylestradiol 35 micrograms and norgestimate 250 micrograms

Pack
126 tablet (6 x 21 tablets)
63 tablet (3 x 21 tablets)

Low strength tablets containing ethinylestradiol 20 micrograms and desogestrel 150 micrograms

Pack
63 tablet (3 x 21 tablets)

Standard strength tablets containing ethinylestradiol 30 micrograms and desogestrel 150 micrograms

Pack
63 tablet (3 x 21 tablets)

Standard strength patch releasing approx 34 micrograms ethinylestradiol and approx 203 micrograms norelgestromin per 24 hours

Pack
9 patch

Low strength ring releasing approx 15 micrograms ethinylestradiol and approx 120 micrograms etonorgestrel per 24 hours

Pack
3 system
  • First Line Drugs
  • Second Line Drugs
  • Specialist Initiated Drugs
  • Specialist Only Drugs
  • Mixed Status